Home/ Stocks/ TLPH

Talphera, Inc. Common Stock

TLPH XNAS

$0.73 -0.06 (-7.81%) ▼ 15-min delayed

Open

$0.78

High

$0.88

Low

$0.70

Volume

535.0K

Market Cap

$37.34M

About Talphera, Inc. Common Stock

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 13 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$1.0K	$-4,436,000	$-0.11
Q2 2025	$0	$-3,489,000	$-0.10
Q1 2025	$27.0K	$-2,593,000	$-0.10
FY 2024	$0	$-13,004,000	$-0.50

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for TLPH yet. Check out our latest market news or earnings calendar.

Get TLPH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Talphera, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.